ASAM VALPROAT DAPAT MENGHAMBAT PERTUMBUHAN PADA PASIEN EPILEPSI ANAK
Article Sidebar
Published:
May 9, 2021
Main Article Content
Article Details
How to Cite
Catur, M. M. (2021). ASAM VALPROAT DAPAT MENGHAMBAT PERTUMBUHAN PADA PASIEN EPILEPSI ANAK. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 6(1), 97-103. Retrieved from https://bapin-ismki.e-journal.id/jimki/article/view/403
Section
Editorial
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1. Maksoud HMA, El-Shazly SM, El Saied MH. Effect of antiepileptic drug (valproic acid) on children growth. Egypt Pediatr Assoc Gaz. 2016;64(2):69–73.
2. Xu X, Zhang H, Xu Y, Zhao Z, Xu D, Wu Y. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy. J Clin Neurosci. 2013;20(11):1492–7.
3. WHO. WHO | Epilepsy Fact sheet. WHO. 2017.
4. Listiana SA, Setiawan D, Susanti. Identifikasi Permasalahan Dosis dan Interaksi Obat pada Pasien Askes dan Umum Penderita Epilepsi di RSUD Prof. Dr. Margono Soekardjo Purwokerto. Pharmacy. 2012;9(2):58–73.
5. Tatum WO. Antiepileptic drugs: adverse effects and drug interactions. Continuum (Minneap Minn). 2010;16(3 Epilepsy):136–58.
6. Rogawski MA, Cavazos JE. Mechanisms of action of antiepileptic drugs. Wyllie’s Treat Epilepsy Princ Pract. 2015;1128.
7. Lee H-S, Wang S-Y, Salter DM, Wang C-C, Chen S-J, Fan H-C. The impact of the use of antiepileptic drugs on the growth of children. BMC Pediatr. 2013;13:211.
8. Kanemura H, Sano F, Maeda YI, Sugita K, Aihara M. Valproate sodium enhances body weight gain in patients with childhood epilepsy: A pathogenic mechanisms and open-label clinical trial of behavior therapy. Seizure. 2012;21(7):496–500.
9. Svalheim S, Sveberg L, Mochol M, Taubøll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12– 7.
10.Grabowski P. Physiology of bone. In: Calcium and Bone Disorders in Children and Adolescents: Second Edition. 2015. 33–55.
11.Clarke B. Normal bone anatomy and physiology. Vol. 3 Suppl 3, Clinical journal of the American Society of Nephrology : CJASN. 2008.
12. Kini U, Nandeesh BN. Physiology of bone formation, remodeling, and metabolism. In: Radionuclide and Hybrid Bone Imaging. 2012. 29–57.
13. Kiranadi B, Winanto A, Manalu W, Handharyani E. Pemberian Asam Valproat pada Induk Tikus Bunting Menghambat Sintesis Insulin pada Sel Otak Anak Tikus (Valproic Acid Administration in Pregnant Rats Inhibits Insulin Synthesis n in Brain Cells of the Offsprings). 2016;49(3).
14. Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res. 2008;78(2–3):171–7.
15. World Health Organization. Epilepsy in the WHO South- East Asian Region. 2017;18–20.
16. Henry TR. Seizures and Epilepsy : Pathophysiology and Principles of Diagnosis. Hosp Physician Epilepsy Board Rev Man. 2012;1(1):1–21.
17. Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P T. 2010;35(7):392–415.
18. Moshé SL, Perucca E, Ryvlin P, Tomson T. Epilepsy: New advances. Vol. 385, The Lancet. 2015. 884–98.
19.Vykuntaraju KN, Bhat S, Sanjay KS, Govindaraju M. Symptomatic west syndrome secondary to Glucose Transporter-1(GLUT1) deficiency with complete response to 4:1 ketogenic diet. Indian J Pediatr. 2014;81(9):934–6.
20. Felton EA. The Generalized Epilepsies: Description, Pathophysiology, Treatment, and Prognosis. Neurol Rep. 2015;11–8.
21. Handbook of Clinical Neurology 3RD Series. Handb Clin Neurol. 2012;108(C):v.
22. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–30.
23. Cook AM, Meriem K. R eview Mechanisms of action of antiepileptic drugs R eview. 2011;8:307–13.
24. Jefferys J. Basic mechanisms of epilepsy. Epilepsia. 2009;15–9.
25. Rogawski M, Cavazos JE. Mechanisms of Action of Antiepileptic Drugs. Wyllie’s Treat Epilepsy. 2014;(6):1–8.
26. McNamara JO. Pharmacotherapy of the Epilepsies. In: Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 12e. 2011. 583–606.
27. Stafstrom CE. Mechanisms of action of antiepileptic drugs: the search for synergy. Curr Opin Neurol. 2010;23(2):157–63.
28. Uusi-Oukari M, Korpi E. Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev. 2010;62(1):97– 135.
29. Brown C. Pharmacological management of epilepsy. Vol. 20, Progress in Neurology and Psychiatry. 2016. p. 27–34.
30. Pack AM. The Association Between Antiepileptic Drugs and Bone Disease. Epilepsy Curr. 2003;3(3):91–5.
31. Singh A, Trevick S. The Epidemiology of Global Epilepsy. Vol. 34, Neurologic Clinics. 2016. p. 837–47.
32. Parakh M, Katewa V. Non- Pharmacologic Management of Epilepsy. Vol. 81, Indian Journal of Pediatrics. 2014. p. 1073–80.
33. Christian Machado Ximenes J, Crisóstomo Lima Verde E, da Graça Naffah-Mazzacoratti M, Socorro de Barros Viana G. Valproic Acid, a Drug with Multiple Molecular Targets Related to Its Potential Neuroprotective Action. Neurosci Med. 2012;3(1):107– 23.
34. Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014;348:g254.
35. Diederich M, Chateauvieux S, Morceau F, Dicato M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. 2010;2010, 201.
36. Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Vol. 11, The Lancet
2. Xu X, Zhang H, Xu Y, Zhao Z, Xu D, Wu Y. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy. J Clin Neurosci. 2013;20(11):1492–7.
3. WHO. WHO | Epilepsy Fact sheet. WHO. 2017.
4. Listiana SA, Setiawan D, Susanti. Identifikasi Permasalahan Dosis dan Interaksi Obat pada Pasien Askes dan Umum Penderita Epilepsi di RSUD Prof. Dr. Margono Soekardjo Purwokerto. Pharmacy. 2012;9(2):58–73.
5. Tatum WO. Antiepileptic drugs: adverse effects and drug interactions. Continuum (Minneap Minn). 2010;16(3 Epilepsy):136–58.
6. Rogawski MA, Cavazos JE. Mechanisms of action of antiepileptic drugs. Wyllie’s Treat Epilepsy Princ Pract. 2015;1128.
7. Lee H-S, Wang S-Y, Salter DM, Wang C-C, Chen S-J, Fan H-C. The impact of the use of antiepileptic drugs on the growth of children. BMC Pediatr. 2013;13:211.
8. Kanemura H, Sano F, Maeda YI, Sugita K, Aihara M. Valproate sodium enhances body weight gain in patients with childhood epilepsy: A pathogenic mechanisms and open-label clinical trial of behavior therapy. Seizure. 2012;21(7):496–500.
9. Svalheim S, Sveberg L, Mochol M, Taubøll E. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12– 7.
10.Grabowski P. Physiology of bone. In: Calcium and Bone Disorders in Children and Adolescents: Second Edition. 2015. 33–55.
11.Clarke B. Normal bone anatomy and physiology. Vol. 3 Suppl 3, Clinical journal of the American Society of Nephrology : CJASN. 2008.
12. Kini U, Nandeesh BN. Physiology of bone formation, remodeling, and metabolism. In: Radionuclide and Hybrid Bone Imaging. 2012. 29–57.
13. Kiranadi B, Winanto A, Manalu W, Handharyani E. Pemberian Asam Valproat pada Induk Tikus Bunting Menghambat Sintesis Insulin pada Sel Otak Anak Tikus (Valproic Acid Administration in Pregnant Rats Inhibits Insulin Synthesis n in Brain Cells of the Offsprings). 2016;49(3).
14. Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res. 2008;78(2–3):171–7.
15. World Health Organization. Epilepsy in the WHO South- East Asian Region. 2017;18–20.
16. Henry TR. Seizures and Epilepsy : Pathophysiology and Principles of Diagnosis. Hosp Physician Epilepsy Board Rev Man. 2012;1(1):1–21.
17. Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P T. 2010;35(7):392–415.
18. Moshé SL, Perucca E, Ryvlin P, Tomson T. Epilepsy: New advances. Vol. 385, The Lancet. 2015. 884–98.
19.Vykuntaraju KN, Bhat S, Sanjay KS, Govindaraju M. Symptomatic west syndrome secondary to Glucose Transporter-1(GLUT1) deficiency with complete response to 4:1 ketogenic diet. Indian J Pediatr. 2014;81(9):934–6.
20. Felton EA. The Generalized Epilepsies: Description, Pathophysiology, Treatment, and Prognosis. Neurol Rep. 2015;11–8.
21. Handbook of Clinical Neurology 3RD Series. Handb Clin Neurol. 2012;108(C):v.
22. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–30.
23. Cook AM, Meriem K. R eview Mechanisms of action of antiepileptic drugs R eview. 2011;8:307–13.
24. Jefferys J. Basic mechanisms of epilepsy. Epilepsia. 2009;15–9.
25. Rogawski M, Cavazos JE. Mechanisms of Action of Antiepileptic Drugs. Wyllie’s Treat Epilepsy. 2014;(6):1–8.
26. McNamara JO. Pharmacotherapy of the Epilepsies. In: Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 12e. 2011. 583–606.
27. Stafstrom CE. Mechanisms of action of antiepileptic drugs: the search for synergy. Curr Opin Neurol. 2010;23(2):157–63.
28. Uusi-Oukari M, Korpi E. Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev. 2010;62(1):97– 135.
29. Brown C. Pharmacological management of epilepsy. Vol. 20, Progress in Neurology and Psychiatry. 2016. p. 27–34.
30. Pack AM. The Association Between Antiepileptic Drugs and Bone Disease. Epilepsy Curr. 2003;3(3):91–5.
31. Singh A, Trevick S. The Epidemiology of Global Epilepsy. Vol. 34, Neurologic Clinics. 2016. p. 837–47.
32. Parakh M, Katewa V. Non- Pharmacologic Management of Epilepsy. Vol. 81, Indian Journal of Pediatrics. 2014. p. 1073–80.
33. Christian Machado Ximenes J, Crisóstomo Lima Verde E, da Graça Naffah-Mazzacoratti M, Socorro de Barros Viana G. Valproic Acid, a Drug with Multiple Molecular Targets Related to Its Potential Neuroprotective Action. Neurosci Med. 2012;3(1):107– 23.
34. Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014;348:g254.
35. Diederich M, Chateauvieux S, Morceau F, Dicato M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. 2010;2010, 201.
36. Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Vol. 11, The Lancet